Local Institution - 602

Chuo-ku, Tokyo 104-0045

0 studies enrolling now · 1 studies all time

What they study most

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma

Studies at this site

• A Study to Determine Dose, Safety, and Efficacy of Durvalumab as Monotherapy and in Combination Therapy in Subjects With Lymphoma or Chronic Lymphocytic Leukemia — Completed